Skip to main content

Table 1 Patient demographics are carefully explored

From: Stereotactic body radiation therapy in the treatment of ovarian cancer

Patient Demographics

Number

Rate

Total patients

35

 

Total lesions

98

 

Patients with 1 lesion

17

49%

Patients with 2 lesions

6

17%

Patients with 3 lesions

2

6%

Patients with 4 lesions

3

9%

Patients with ≥5 lesions

7

20%

Median age at diagnosis (years)

62.8 (32.7–80.6)

 

ECOG 0

21

60%

ECOG 1

11

31%

ECOG 2

1

3%

ECOG 3

2

6%

ECOG 4

0

0%

Histology

 Serous papillary adenocarcinoma

23

66%

 Mixed

1

3%

 Clear cell

1

3%

 Transitional cell

1

3%

 Granulosa cell

1

3%

 Endometrioid

2

6%

 Carcinosarcoma (mixed Mullerian)

2

6%

 Poorly differentiated / Undifferentiated

3

9%

 Mucinous

1

3%

 Positive BRCA 1

5

14%

 Positive HRD

2

6%

 Neoadjuvant chemotherapy

8

23%

 No neoadjuvant chemotherapy

27

77%

 Gross residual post-op

14

40%

 No gross residual post-op

21

60%

 Median post-chemotherapy CA125

18

 

 Median pre-SBRT SUV

5.5

 

Staging at Diagnosis

 Stage I

5

14%

 Stage II

3

9%

 Stage III

18

51%

 Stage IV

9

26%

 Grade 1

1

3%

 Grade 2

4

11%

 Grade 3

26

74%

 Grade NA

4

11%